Acetic Acid

Acetic Acid

SCHEMBL3474894

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].NCCN.[Fe+3].[NH4+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.53
CA4 P22748 3/20 0.39
PAOX Q6QHF9 3/20 0.38
LMNA P02545 2/20 0.35
ALOX15 P16050 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
GABRR1 P24046 2/20 0.32
FFAR3 O14843 2/20 0.32
HDAC3 O15379 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC8 Q9BY41 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GLRA1 P23415 1/20 0.32
SLC6A9 P48067 1/20 0.32
OR51E2 Q9H255 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL8377120 1.00 CA1 (0.53) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL16161243 1.00 CA1 (0.53) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL10700061 1.00 CA1 (0.53) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL8431532 0.97 CA1 (0.50) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL9300614 0.97 CA1 (0.50) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL9656590 0.97 CA1 (0.50) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL11464429 0.97 CA1 (0.57) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL927347 0.97 CA1 (0.57) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL468685 0.93 CA1 (0.60) CA1CA4PAOXLMNAALOX15
Acetic Acid SCHEMBL17744757 0.93 CA1 (0.53) CA1CA4PAOXLMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119735283-A Fluorine removing agent for sewage and preparation method thereof 廊坊明泉化工建材有限公司 2025-04-01 CN claimed
CN-117550676-B Dual-functional polymeric material and preparation method and application thereof 中国科学院合肥物质科学研究院 2024-04-09 CN claimed
CN-117550676-A Dual-functional polymeric material and preparation method and application thereof 中国科学院合肥物质科学研究院 2024-02-13 CN claimed
CN-115394989-A Preparation method of high-power graphite composite material 四川坤天新能源科技有限公司 2022-11-25 CN claimed
CN-109689038-B Aqueous preparation containing 5-aminoacetopropionic acids 思佰益药业股份有限公司 2022-05-13 CN claimed
CN-106474098-B Immune tolerance inducer 思佰益药业股份有限公司 2020-06-05 CN claimed
CN-111205572-A Fluoropolymer wire and cable material and preparation method thereof 何先鹏 2020-05-29 CN claimed
CN-106661550-B Agent for improving normal development rate of fertilized egg 思佰益药业股份有限公司 2020-03-20 CN claimed
EP-2875813-B1 PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION SBI PHARMACEUTICALS CO LTD (JP) 2018-04-18 EP claimed
US-20170056351-A1 COMPOSITION FOR INDUCING TUMOR IMMUNITY UNIVERISTY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, JAPAN (JP) 2017-03-02 US claimed
US-9351949-B2 Prophylactic/therapeutic agent for influenza virus infection SBI PHARMACEUTICALS CO., LTD. (JP) 2016-05-31 US claimed
US-20150164838-A1 PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION SBI PHARMACEUTICALS CO., LTD. (JP) 2015-06-18 US claimed
EP-2875813-A1 PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION SBI Pharmaceuticals Co., Ltd. (JP) 2015-05-27 EP claimed
US-4707434-A Color image forming method comprising processing with a bleach-fixing solution KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1987-11-17 US claimed
CN-119735283-A Fluorine removing agent for sewage and preparation method thereof 廊坊明泉化工建材有限公司 2025-04-01 CN disclosed
CN-119735283-A Fluorine removing agent for sewage and preparation method thereof 廊坊明泉化工建材有限公司 2025-04-01 CN disclosed
CN-118978414-A Bag-type novel slow release fertilizer capable of efficiently supplementing iron nutrient elements and preparation method thereof 广西壮族自治区林业科学研究院 2024-11-19 CN disclosed
US-4120725-A POLYMERS OF ACRYLIC AMIDES AND OF VINYL OR ALLYL ALCOHOLS, VINYL IMIDES OR AMIDES OR VINYL MORPHOLINE FUJI PHOTO FILM CO., LTD. (JP) 1978-10-17 US disclosed
US-4052212-A ETHER-ESTER KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) 1977-10-04 US disclosed
US-4012258-A POLY-FLUORO-ALKYL MAGENTA OR CYAN COUPLER KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) 1977-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164838-A1 PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION ALAD, AADAT, ATP5MG CA1 228/4885CA4 751/4885PAOX 4231/4885
US-20170056351-A1 COMPOSITION FOR INDUCING TUMOR IMMUNITY IFNG, MYD88, IL2 CA1 387/4885CA4 909/4885PAOX 1547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.